Status: Not yet recruiting
Neurofeedback in Clinical High Risk
The goal of this trial is to test whether fMRI based neurofeedback from default mode network (DMN) will reduce DMN hyperconnectivity in clinical high risk individuals, which will lead to reductions in clinical symptoms and improve cognitive performance.
Participants needed: 40
Trial details
Age: 12-30Biological sex: AllType: InterventionalSponsor: Boston VA Research Institute, Inc.Updated: Jul 9, 2024
Eligibility criteria
12-30 years old [+5]
Meeting DSM-5 criteria for lifetime psychotic disorder, including affective psyc... [+14]